Last $4.98 USD
Change Today +0.215 / 4.51%
Volume 146.1K
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John M. Gill CPA

AgeTotal Calculated CompensationThis person is connected to 53 board members in 3 different organizations across 4 different industries.

See Board Relationships
62$80,614
As of Fiscal Year 2013

Background*

Mr. John M. Gill, CPA co-founded Tetralogic Pharmaceuticals, Inc. in 2003 and served as its President and Chief Executive Officer until August 12, 2013. Mr. Gill held senior management positions in operations and finance at SmithKline Beecham Corporation and 3 Dimensional Pharmaceuticals. Mr. Gill served as the Chief Financial Officer of 3-dimensional Pharmaceuticals Inc. from May 2001 to May 5, 2002. He served as the Chief Operating Officer of 3-Dimensional Pharmaceuticals ...

Read Full Background

Corporate Headquarters*

343 Phoenixville Pike
Malvern, Pennsylvania 19355

United States

Phone: 610-889-9900
Fax: 610-889-9994

Board Members Memberships*

Former Director
Former Director
Director
2002-N/A
Former Chief Operating Officer, Executive Vice President and Director
2003-2014
Co-Founder
2007-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee

Education*

BA 1975
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$58,000
Total Calculated Compensation$80,614
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TLOG:US $4.98 USD +0.215

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Moshe Manor Chief Executive Officer and President
Protalix BioTherapeutics, Inc.
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TETRALOGIC PHARMACEUTICALS C, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.